INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
140.53 USD
-3.46 (-2.4%)
140.1 USD
-0.43 (-0.31%)
Overall INSP gets a fundamental rating of 6 out of 10. We evaluated INSP against 187 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP shows excellent growth, but is valued quite expensive already. These ratings would make INSP suitable for growth investing!
1. Profitability
1.1 Basic Checks
INSP had positive earnings in the past year.
In the past year INSP had a positive cash flow from operations.
In the past 5 years INSP reported 4 times negative net income.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP has a Return On Assets of 5.52%. This is amongst the best in the industry. INSP outperforms 82.89% of its industry peers.
INSP's Return On Equity of 6.69% is amongst the best of the industry. INSP outperforms 81.28% of its industry peers.
INSP's Return On Invested Capital of 4.82% is fine compared to the rest of the industry. INSP outperforms 75.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a Profit Margin of 5.05%. This is in the better half of the industry: INSP outperforms 77.54% of its industry peers.
INSP has a better Operating Margin (4.16%) than 69.52% of its industry peers.
The Gross Margin of INSP (84.92%) is better than 94.12% of its industry peers.
In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 18.81 indicates that INSP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 18.81, INSP belongs to the best of the industry, outperforming 94.65% of the companies in the same industry.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.81 |
ROIC/WACC0.55
WACC8.81%
2.3 Liquidity
A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
INSP's Current ratio of 5.29 is fine compared to the rest of the industry. INSP outperforms 79.68% of its industry peers.
INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a Quick ratio of 4.01. This is in the better half of the industry: INSP outperforms 74.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.65% over the past year.
The Revenue has grown by 16.81% in the past year. This is quite good.
INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.35% on average per year.
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.59% yearly.
EPS Next Y-45.95%
EPS Next 2Y0.41%
EPS Next 3Y15.46%
EPS Next 5Y21.35%
Revenue Next Year13.16%
Revenue Next 2Y12.49%
Revenue Next 3Y12.39%
Revenue Next 5Y11.59%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 68.89, the valuation of INSP can be described as expensive.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 66.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of INSP to the average of the S&P500 Index (26.29), we can say INSP is valued expensively.
The Price/Forward Earnings ratio is 80.57, which means the current valuation is very expensive for INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than 66.84% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.51, INSP is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.89 | ||
| Fwd PE | 80.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 64.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than 75.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.33 | ||
| EV/EBITDA | 71.98 |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 15.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.41%
EPS Next 3Y15.46%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
140.53
-3.46 (-2.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.83%
Inst Owner Change-6.75%
Ins Owners0.75%
Ins Owner Change0.1%
Market Cap4.08B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts79.23
Price Target128.11 (-8.84%)
Short Float %12.79%
Short Ratio2.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)0.77%
PT rev (3m)-13.37%
EPS NQ rev (1m)0.7%
EPS NQ rev (3m)1.61%
EPS NY rev (1m)81.38%
EPS NY rev (3m)83.02%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.89 | ||
| Fwd PE | 80.57 | ||
| P/S | 4.63 | ||
| P/FCF | 41.33 | ||
| P/OCF | 30.55 | ||
| P/B | 6.13 | ||
| P/tB | 6.13 | ||
| EV/EBITDA | 71.98 |
EPS(TTM)2.04
EY1.45%
EPS(NY)1.74
Fwd EY1.24%
FCF(TTM)3.4
FCFY2.42%
OCF(TTM)4.6
OCFY3.27%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 18.81 |
F-Score8
WACC8.81%
ROIC/WACC0.55
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-45.95%
EPS Next 2Y0.41%
EPS Next 3Y15.46%
EPS Next 5Y21.35%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.16%
Revenue Next 2Y12.49%
Revenue Next 3Y12.39%
Revenue Next 5Y11.59%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year638.4%
EBIT Next 3Y118.04%
EBIT Next 5Y73.68%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 3 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Overvalued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -45.95% in the next year.